Pricing Log in Create free account

Drugs Made In America Acquisition Corp. (DMAA) vs TRG Latin America Acquisitions Corp. (TRGS)

Drugs Made In America Acquisition Corp. and TRG Latin America Acquisitions Corp. are both Shell Companies companies. Drugs Made In America Acquisition Corp. and TRG Latin America Acquisitions Corp. are of similar size ($264.4M and $259.4M).

Valuation

Metric DMAA TRGS Shell Companies median
P/E — — 30.90
P/S — — —
P/B — — 84.01
Price to free cash flow — — —
EV/EBITDA — — —
EV/Sales — — —
Earnings yield — — 2.82%
Free cash flow yield — — 0.00%

Profitability

Metric DMAA TRGS Shell Companies median
Gross margin — — —
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin — — 0.00%
Return on equity — — (0.35%)
Return on assets — — 2.50%
Return on invested capital — — 0.00%

Growth

Metric DMAA TRGS Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) — — 81.42%
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — —

Health

Metric DMAA TRGS Shell Companies median
Debt to equity — — 0.00
Current ratio — — 1.41
Net debt to EBITDA — — 0.33

Dividend

Metric DMAA TRGS Shell Companies median
Dividend yield — — —
Payout ratio — — —

Size

Metric DMAA TRGS Shell Companies median
Market cap 264.37m 259.37m 238.75m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack